StockMacro
Company, fund or insider

Help

Menu

Viemed Healthcare

$8.52 -11% in 6 monthsMarket cap $322.8M

VMD on XNAS, Health Care, Viemed Healthcare, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue up 22% over 12 months to $310.4M and profit up 15%, and shares rose 34% in 12 months.

  • GoodLatest quarter revenue up 12% to $80.7M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.

Industry
Services-misc health & allied services, nec (Health Care)
Employees
1,382
Website
viemed.com
Listed
Nasdaq, US
Last results
4 Nov 2026
Next results
expected around 3 Mar 2027 (an estimate: a year ago it reported on 4 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $80.7M, net income $4.6M.
Quarter to 31 Dec 2021: revenue $32.0M, net income $4.1MQuarter to 31 Dec 2021: revenue $32.0M, net income $4.1MQuarter to 31 Mar 2022: revenue $32.3M, net income $1.8MQuarter to 31 Mar 2022: revenue $32.3M, net income $1.8MQuarter to 30 Jun 2022: revenue $33.3M, net income $967KQuarter to 30 Jun 2022: revenue $33.3M, net income $967KQuarter to 30 Sep 2022: revenue $35.8M, net income $1.1MQuarter to 30 Sep 2022: revenue $35.8M, net income $1.1MQuarter to 31 Dec 2022: revenue $37.5M, net income $2.4MQuarter to 31 Dec 2022: revenue $37.5M, net income $2.4MQuarter to 31 Mar 2023: revenue $39.6M, net income $1.5MQuarter to 31 Mar 2023: revenue $39.6M, net income $1.5MQuarter to 30 Jun 2023: revenue $43.3M, net income $2.3MQuarter to 30 Jun 2023: revenue $43.3M, net income $2.3MQuarter to 30 Sep 2023: revenue $49.4M, net income $2.9MQuarter to 30 Sep 2023: revenue $49.4M, net income $2.9MQuarter to 31 Dec 2023: revenue $50.7M, net income $3.5MQuarter to 31 Dec 2023: revenue $50.7M, net income $3.5MQuarter to 31 Mar 2024: revenue $50.6M, net income $1.6MQuarter to 31 Mar 2024: revenue $50.6M, net income $1.6MQuarter to 30 Jun 2024: revenue $55.0M, net income $1.5MQuarter to 30 Jun 2024: revenue $55.0M, net income $1.5MQuarter to 30 Sep 2024: revenue $58.0M, net income $3.9MQuarter to 30 Sep 2024: revenue $58.0M, net income $3.9MQuarter to 31 Dec 2024: revenue $60.7M, net income $4.3MQuarter to 31 Dec 2024: revenue $60.7M, net income $4.3MQuarter to 31 Mar 2025: revenue $59.1M, net income $2.6MQuarter to 31 Mar 2025: revenue $59.1M, net income $2.6MQuarter to 30 Jun 2025: revenue $63.1M, net income $3.2MQuarter to 30 Jun 2025: revenue $63.1M, net income $3.2MQuarter to 30 Sep 2025: revenue $71.9M, net income $3.5MQuarter to 30 Sep 2025: revenue $71.9M, net income $3.5MQuarter to 31 Dec 2025: revenue $76.2M, net income $5.6MQuarter to 31 Dec 2025: revenue $76.2M, net income $5.6MQuarter to 31 Mar 2026: revenue $75.4M, net income $2.6MQuarter to 31 Mar 2026: revenue $75.4M, net income $2.6MQuarter to 30 Jun 2026: revenue $78.1M, net income $2.8MQuarter to 30 Jun 2026: revenue $78.1M, net income $2.8MQuarter to 30 Sep 2026: revenue $80.7M, net income $4.6MQuarter to 30 Sep 2026: revenue $80.7M, net income $4.6M
31 Dec 2021RevenueNet incometallest bar $80.7M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$80.7M$4.6M
30 Jun 2026$78.1M$2.8M
31 Mar 2026$75.4M$2.6M
31 Dec 2025$76.2M$5.6M
30 Sep 2025$71.9M$3.5M
30 Jun 2025$63.1M$3.2M
31 Mar 2025$59.1M$2.6M
31 Dec 2024$60.7M$4.3M
30 Sep 2024$58.0M$3.9M
30 Jun 2024$55.0M$1.5M
31 Mar 2024$50.6M$1.6M
31 Dec 2023$50.7M$3.5M
30 Sep 2023$49.4M$2.9M
30 Jun 2023$43.3M$2.3M
31 Mar 2023$39.6M$1.5M
31 Dec 2022$37.5M$2.4M
30 Sep 2022$35.8M$1.1M
30 Jun 2022$33.3M$967K
31 Mar 2022$32.3M$1.8M
31 Dec 2021$32.0M$4.1M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $310.4M $254.8M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +22% +3.8%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $15.6M $13.6M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $0.38 $0.34
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 57.4% 57.9% 56.0%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 7.8% 8.3% 7.8%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 5.0% 5.3% 5.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 11.0% -9.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $21.4M $5.4M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $9.7M $11.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $5.0M $21.1M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$4.7M (net cash) $10.0M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.03 0.06
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $3.96
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 20.7 24.7
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.0 1.1
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.0 1.2
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.2 4.1

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Viemed HealthcareVMD (this company) $322.8M20.71.0+22%5.0%
Park Dental PartnersPARK $94.3M––––
agilon healthAGL $1.5Bloss0.25+2.0%-1.5%
ProgynyPGNY $2.6B28.92.0+5.5%6.8%
Cryo-Cell InternationalCCEL $33.5Mloss1.1-2.0%-6.2%
Sotera HealthSHC $4.5B26.23.7+6.9%14.1%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+12%

$80.7M vs $71.9M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+13%

$8.6M vs $7.6M (quarter ended 30 Sep 2026)

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+0.6%

165 13F filers vs 164

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

71%

26.7M shares held by 13F filers (30 Sep 2026) of 37.9M outstanding (27 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.0%

1.5M shares sold short (30 Oct 2026) of 37.9M outstanding (27 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

8.5

1.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-1.7%

1.5M shares sold short in the report before, 1.5M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

20%

20% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 42%

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$30K

4 quarters

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

0

0 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

0 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 1.5M, 3.8× a year earlier

Price $8.52 on 20 Nov 2026, +34% over 12 months (12-month range $6.35 to $12.33)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $1.6M in the last 12 months (the 12 months before: -$2.1M).
Revenue per quarter. Revenue $80.7M in the latest quarter, +12% on a year earlier.
Capital spending per quarter. Capital spending $8.6M in the latest quarter, +13% on a year earlier.
Institutional holders (13F filers). 165 13F filers reported holding it in the latest 13F quarter, +32% on a year earlier.
Lobbying spend. Lobbying spend: $30K published in the last 12 months (none in the 12 months before).

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeShort interest spike: short interest spike, 1.5M vs usual 428K (2026-10-30); 3.8x the same period a year earlier
27 Oct 2026Sharp changeShort interest spike: short interest spike, 1.5M vs usual 407K (2026-10-15); 4.0x the same period a year earlier
13 Oct 2026Sharp changeShort interest spike: short interest spike, 1.6M vs usual 404K (2026-09-30); 3.9x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 1.3M vs usual 404K (2026-09-15); 2.9x the same period a year earlier
15 Sep 2026Sharp changeShort interest spike: short interest spike, 1.2M vs usual 404K (2026-08-31); 2.9x the same period a year earlier
1 Sep 2026Sharp changeShort interest spike: short interest spike, 787K vs usual 404K (2026-08-14); 1.9x the same period a year earlier
18 Aug 2026Sharp changeShort interest spike: short interest spike, 672K vs usual 404K (2026-07-31); 1.4x the same period a year earlier
4 Jun 20268-K and other filingsDirector or officer change
4 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Jun 20258-K and other filingsDirector or officer change
8 May 2025Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 15.5M vs usual 7.7M (2025-03-31); 2.6x the same period a year earlier
14 Apr 20258-K and other filingsDirector or officer change
14 Apr 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Jun 20248-K and other filingsDirector or officer change
6 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Nov 2023Sharp changeQuarterly revenue change: quarterly revenue change, 49.4M vs usual 34.5M (2023-09-30); 1.4x the same period a year earlier
19 Sep 2023Sharp changeShort interest spike: short interest spike, 512K vs usual 137K (2023-08-31); 3.7x the same period a year earlier
29 Aug 2023Sharp changeShort interest spike: short interest spike, 539K vs usual 137K (2023-08-15); 3.1x the same period a year earlier
15 Aug 2023Sharp changeShort interest spike: short interest spike, 581K vs usual 137K (2023-07-31); 3.4x the same period a year earlier
1 Aug 2023Sharp changeShort interest spike: short interest spike, 629K vs usual 137K (2023-07-14); 2.5x the same period a year earlier
18 Jul 2023Sharp changeShort interest spike: short interest spike, 589K vs usual 137K (2023-06-30); 1.5x the same period a year earlier
1 Jun 20238-K and other filingsCompleted an acquisition or asset sale
29 Nov 20228-K and other filingsA major agreement ended
17 Oct 2022Lobbying filinglobbying engagement terminated (FORBES-TATE)
20 Apr 2022Lobbying filinglobbying engagement terminated (CJ LAKE, LLC)
Insider net buying (open market)
Month from 1 Dec 2022: -$265K published
Month from 1 Mar 2023: -$162K published
Month from 1 Jun 2023: -$140K published
Month from 1 May 2024: $20K published
Month from 1 Nov 2024: -$1.4M published
Month from 1 Mar 2025: -$91K published
Month from 1 Jul 2025: -$1.6M published
Month from 1 Aug 2025: -$403K published
Month from 1 Mar 2026: -$1.2M published
Month from 1 Jun 2026: -$347K published
Revenue per quarter
Quarter ended 31 Dec 2021: $32.0M, +2.4% on a year earlier; public on 8 Mar 2022
Quarter ended 31 Mar 2022: $32.3M, +14% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $33.3M, +22% on a year earlier; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $35.8M, +22% on a year earlier; public on 2 Nov 2022
Quarter ended 31 Dec 2022: $37.5M, +17% on a year earlier; public on 3 Mar 2023
Quarter ended 31 Mar 2023: $39.6M, +23% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $43.3M, +30% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $49.4M, +38% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $50.7M, +35% on a year earlier; public on 7 Mar 2024
Quarter ended 31 Mar 2024: $50.6M, +28% on a year earlier; public on 7 May 2024
Quarter ended 30 Jun 2024: $55.0M, +27% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $58.0M, +17% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $60.7M, +20% on a year earlier; public on 11 Mar 2025
Quarter ended 31 Mar 2025: $59.1M, +17% on a year earlier; public on 8 May 2025
Quarter ended 30 Jun 2025: $63.1M, +15% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $71.9M, +24% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $76.2M, +26% on a year earlier; public on 5 Mar 2026
Quarter ended 31 Mar 2026: $75.4M, +28% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $78.1M, +24% on a year earlier; public on 4 Aug 2026
Quarter ended 30 Sep 2026: $80.7M, +12% on a year earlier; public on 5 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $6.7M, +38% on a year earlier; public on 8 Mar 2022
Quarter ended 31 Mar 2022: $4.0M, +121% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $7.0M, +116% on a year earlier; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $6.3M, -21% on a year earlier; public on 2 Nov 2022
Quarter ended 31 Dec 2022: $5.6M, -16% on a year earlier; public on 3 Mar 2023
Quarter ended 31 Mar 2023: $4.7M, +18% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $6.1M, -13% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $7.4M, +17% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $7.9M, +42% on a year earlier; public on 7 Mar 2024
Quarter ended 31 Mar 2024: $6.0M, +28% on a year earlier; public on 7 May 2024
Quarter ended 30 Jun 2024: $8.9M, +47% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $11.0M, +49% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $11.8M, +49% on a year earlier; public on 11 Mar 2025
Quarter ended 31 Mar 2025: $15.5M, +158% on a year earlier; public on 8 May 2025
Quarter ended 30 Jun 2025: $8.1M, -9.0% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $7.6M, -31% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $8.7M, -26% on a year earlier; public on 5 Mar 2026
Quarter ended 31 Mar 2026: $6.7M, -57% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $8.5M, +4.1% on a year earlier; public on 4 Aug 2026
Quarter ended 30 Sep 2026: $8.6M, +13% on a year earlier; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 79; public on 14 Feb 2022
31 Mar 2022 report: 82; public on 16 May 2022
30 Jun 2022 report: 70; public on 15 Aug 2022
30 Sep 2022 report: 62; public on 14 Nov 2022
31 Dec 2022 report: 75; public on 14 Feb 2023
31 Mar 2023 report: 80; public on 15 May 2023
30 Jun 2023 report: 96; public on 14 Aug 2023
30 Sep 2023 report: 106; public on 14 Nov 2023
31 Dec 2023 report: 97; public on 14 Feb 2024
31 Mar 2024 report: 108; public on 15 May 2024
30 Jun 2024 report: 114; public on 14 Aug 2024
30 Sep 2024 report: 118; public on 14 Nov 2024
31 Dec 2024 report: 139; public on 14 Feb 2025
31 Mar 2025 report: 136; public on 15 May 2025
30 Jun 2025 report: 121; public on 14 Aug 2025
30 Sep 2025 report: 125; public on 14 Nov 2025
31 Dec 2025 report: 126; public on 17 Feb 2026
31 Mar 2026 report: 145; public on 15 May 2026
30 Jun 2026 report: 164; public on 14 Aug 2026
30 Sep 2026 report: 165; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $10K published
Quarter from 1 Oct 2026: $30K published

What is unusual now

  • Made public in the last 90 days: it had 1.5M shares sold short in the 30 Oct 2026 report, 3.8× the same report last year; it also had 1.5M shares sold short in the 15 Oct 2026 report, 4.0× the same report last year. 6 sharp changes in all.
  • Short interest spike: had 1.5M shares sold short in the 30 Oct 2026 report, 3.8× the same report last year Public on 11 Nov 2026.
  • Insider net buying (open market): Insiders sold a net $1.6M in the last 12 months (the 12 months before: -$2.1M).
  • Revenue per quarter: Revenue $80.7M in the latest quarter, +12% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 17 insider trades

No trades in the last 90 days; the latest was filed 26 Jun 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
26 Jun 2026Timothy SmokoffDirectorSell20,000$11.50$230KForm 4
26 Jun 2026William FrazierChief Medical OfficerSellafter exercising options10,000$11.72$117KForm 4
20 Mar 2026Michael MoorePresidentSell136,802$9.05$1.2MForm 4
14 Aug 2025Jerome CambreVice President of SalesSell4,880$7.32$36KForm 4
13 Aug 2025Michael MoorePresidentSell50,090$7.33$367KForm 4
1 Jul 2025Michael MoorePresidentSellafter exercising options181,316$6.92$1.3MForm 4
1 Jul 2025Nitin KaushalDirectorSellafter exercising options7,048$6.91$49KForm 4
30 Jun 2025Nitin KaushalDirectorSellafter exercising options42,952$7.01$301KForm 4

165 institutions reported shares at the end of Q3 2026, 71% of the shares outstanding; 24 opened a position, 22 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.4.9M13.0%$45.0M+154K+3.2%
Forager Capital Management, LLC1.8M4.68%$16.1M-368K-17%
Vanguard Capital Management LLC1.3M3.49%$12.0M-2800%
Ameriprise Financial Inc1.3M3.43%$11.8M+295K+29%
Geode Capital Management, LLC1.2M3.09%$10.7M+198K+20%
Arrowstreet Capital, Limited Partnership1.0M2.75%$9.5M+257K+33%
State Street Corp757K2.00%$6.9M-4,873-0.6%
Nantahala Capital Management, LLC715K1.89%$6.5M-550K-43%
Martin & Co Inc702K1.85%$6.4M+361K+106%
Panagora Asset Management Inc597K1.58%$5.4M+59K+11%

Company events

All 17 company events

In 12 months: 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
4 Jun 2026Director or officer changeSame filing: shareholder vote results8-K
7 Nov 2025Signed a major agreement8-K
9 Jun 2025Signed a major agreement8-K
5 Jun 2025Director or officer changeSame filing: shareholder vote results8-K
14 Apr 2025Director or officer change8-K
6 Jun 2024Director or officer changeSame filing: shareholder vote results8-K
29 May 2024Signed a major agreementSame filing: took on new debt8-K
1 Jun 2023Completed an acquisition or asset saleSame filing: took on new debt8-K

Reported lobbying spend: $30K in Q3 2026, $10K in Q4 2021. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Aug 2022EndedForbes-Tatefor Viemed Healthcare, Inc.Not statedFiling
1 Jan 2022EndedCJ Lake, LLCfor The Picard Group Obo ViemedNot statedFiling
1 Aug 2020NewForbes-Tatefor Viemed Healthcare, Inc.Issues related to home ventilation policies.Health issuesFiling
18 Mar 2020NewCJ Lake, LLCfor The Picard Group Obo Viemedprovisions related to expanding access to non-invasive ventilation servicesHealth issues, Medicare/MedicaidFiling
18 Mar 2020NewThe Picard Group, LLCfor Viemedprovisions related to expanding access to non-invasive ventilation servicesHealth issues, Medicare/MedicaidFiling
30 Mar 2019EndedK&L Gates, LLPfor Sleep Management LLC D/B/A ViemedNot statedFiling
19 Nov 2015NewK&L Gates, LLPfor Sleep Management LLC D/B/A ViemedMedicare coverage and reimbursement issues.Medicare/MedicaidFiling
Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

1 Sep 2020confirmed

Confirmed across sources Filings + Financials and Short interest and volume

Viemed Healthcare (VMD): reported revenue of $42.9M for the quarter ended 30 Jun 2020, 1.9× the same quarter last year, while it had 1.1M shares sold short in the 14 Aug 2020 report, 22× the same report last year. Two unrelated kinds of activity within 35 days.

  • Financials: Quarterly revenue change, became public on 11 Aug 2020
  • Short interest and volume: Short interest spike, became public on 26 Aug 2020
  • Short interest and volume: Short interest spike, became public on 11 Sep 2020
2018-06-30: $15.5M2018-09-30: $17.2M2018-12-31: $18.4M2019-03-31: $18.1M2019-06-30: $22.5M2019-09-30: $23.5M2019-12-31: $21.4M2020-03-31: $23.8M2020-06-30: $42.9M
The quarter ended 30 Jun 2020 against the 8 quarters before it. this quarterearliernormal: $19.9M
See the evidence (3 changes)

Financials: Quarterly revenue change became public on 11 Aug 2020

Viemed Healthcare reported revenue of $42.9M for the quarter ended 30 Jun 2020, 1.9× the same quarter last year.

This period
$42.9M (the quarter ended 30 Jun 2020)
Normal quarter (median of 8 earlier)
$19.9M
Typical spread (median absolute deviation)
$2.7M
How far from its usual level
+5.7
Same quarter last year
$22.5M
History used
822 days
2018-06-30: $15.5M2018-09-30: $17.2M2018-12-31: $18.4M2019-03-31: $18.1M2019-06-30: $22.5M2019-09-30: $23.5M2019-12-31: $21.4M2020-03-31: $23.8M2020-06-30: $42.9M
the quarter ended 30 Jun 20208 earlier quartersnormal: $19.9M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 26 Aug 2020

Viemed Healthcare had 1.1M shares sold short in the 14 Aug 2020 report, 22× the same report last year.

This period
1.1M (the 14 Aug 2020 report)
Normal report (median of 24 earlier)
133K
Typical spread (median absolute deviation)
107K
How far from its usual level
+6.1
Same report last year
50K
History used
365 days
2019-08-15: 50K2019-08-30: 19K2019-09-13: 26K2019-09-30: 34K2019-10-15: 33K2019-10-31: 25K2019-11-15: 17K2019-11-29: 93K2019-12-13: 93K2019-12-31: 93K2020-01-15: 84K2020-01-31: 153K2020-02-14: 127K2020-02-28: 138K2020-03-13: 217K2020-03-31: 546K2020-04-15: 400K2020-04-30: 448K2020-05-15: 311K2020-05-29: 385K2020-06-15: 531K2020-06-30: 2.1M2020-07-15: 1.5M2020-07-31: 1.7M2020-08-14: 1.1M
the 14 Aug 2020 report24 earlier reportsnormal: 133K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Sep 2020

Viemed Healthcare had 933K shares sold short in the 31 Aug 2020 report, 49× the same report last year.

This period
933K (the 31 Aug 2020 report)
Normal report (median of 24 earlier)
146K
Typical spread (median absolute deviation)
124K
How far from its usual level
+4.3
Same report last year
19K
History used
382 days
2019-08-30: 19K2019-09-13: 26K2019-09-30: 34K2019-10-15: 33K2019-10-31: 25K2019-11-15: 17K2019-11-29: 93K2019-12-13: 93K2019-12-31: 93K2020-01-15: 84K2020-01-31: 153K2020-02-14: 127K2020-02-28: 138K2020-03-13: 217K2020-03-31: 546K2020-04-15: 400K2020-04-30: 448K2020-05-15: 311K2020-05-29: 385K2020-06-15: 531K2020-06-30: 2.1M2020-07-15: 1.5M2020-07-31: 1.7M2020-08-14: 1.1M2020-08-31: 933K
the 31 Aug 2020 report24 earlier reportsnormal: 146K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 11 Nov 2026Short interest and volume change

    had 1.5M shares sold short in the 30 Oct 2026 report, 3.8× the same report last year.

    Same report last year: 394K; its normal report is 428K.

    See the evidence
    This period
    1.5M (the 30 Oct 2026 report)
    Normal report (median of 24 earlier)
    428K
    Typical spread (median absolute deviation)
    74K
    How far from its usual level
    +9.9
    Same report last year
    394K
    History used
    2,633 days
    2025-10-31: 394K2025-11-14: 406K2025-11-28: 394K2025-12-15: 387K2025-12-31: 325K2026-01-15: 358K2026-01-30: 371K2026-02-13: 355K2026-02-27: 348K2026-03-13: 450K2026-03-31: 391K2026-04-15: 351K2026-04-30: 447K2026-05-15: 409K2026-05-29: 503K2026-06-15: 465K2026-06-30: 519K2026-07-15: 747K2026-07-31: 672K2026-08-14: 787K2026-08-31: 1.2M2026-09-15: 1.3M2026-09-30: 1.6M2026-10-15: 1.5M2026-10-30: 1.5M
    the 30 Oct 2026 report24 earlier reportsnormal: 428K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 27 Oct 2026Short interest and volume change

    had 1.5M shares sold short in the 15 Oct 2026 report, 4.0× the same report last year.

    Same report last year: 384K; its normal report is 407K.

    See the evidence
    This period
    1.5M (the 15 Oct 2026 report)
    Normal report (median of 24 earlier)
    407K
    Typical spread (median absolute deviation)
    54K
    How far from its usual level
    +14.0
    Same report last year
    384K
    History used
    2,618 days
    2025-10-15: 384K2025-10-31: 394K2025-11-14: 406K2025-11-28: 394K2025-12-15: 387K2025-12-31: 325K2026-01-15: 358K2026-01-30: 371K2026-02-13: 355K2026-02-27: 348K2026-03-13: 450K2026-03-31: 391K2026-04-15: 351K2026-04-30: 447K2026-05-15: 409K2026-05-29: 503K2026-06-15: 465K2026-06-30: 519K2026-07-15: 747K2026-07-31: 672K2026-08-14: 787K2026-08-31: 1.2M2026-09-15: 1.3M2026-09-30: 1.6M2026-10-15: 1.5M
    the 15 Oct 2026 report24 earlier reportsnormal: 407K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 10 Oct 2026Short interest and volume change

    had 1.6M shares sold short in the 30 Sep 2026 report, 3.9× the same report last year.

    Same report last year: 403K; its normal report is 404K.

    See the evidence
    This period
    1.6M (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    404K
    Typical spread (median absolute deviation)
    48K
    How far from its usual level
    +16.4
    Same report last year
    403K
    History used
    2,603 days
    2025-09-30: 403K2025-10-15: 384K2025-10-31: 394K2025-11-14: 406K2025-11-28: 394K2025-12-15: 387K2025-12-31: 325K2026-01-15: 358K2026-01-30: 371K2026-02-13: 355K2026-02-27: 348K2026-03-13: 450K2026-03-31: 391K2026-04-15: 351K2026-04-30: 447K2026-05-15: 409K2026-05-29: 503K2026-06-15: 465K2026-06-30: 519K2026-07-15: 747K2026-07-31: 672K2026-08-14: 787K2026-08-31: 1.2M2026-09-15: 1.3M2026-09-30: 1.6M
    the 30 Sep 2026 report24 earlier reportsnormal: 404K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 25 Sep 2026Short interest and volume change

    had 1.3M shares sold short in the 15 Sep 2026 report, 2.9× the same report last year.

    Same report last year: 461K; its normal report is 404K.

    See the evidence
    This period
    1.3M (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    404K
    Typical spread (median absolute deviation)
    48K
    How far from its usual level
    +12.9
    Same report last year
    461K
    History used
    2,588 days
    2025-09-15: 461K2025-09-30: 403K2025-10-15: 384K2025-10-31: 394K2025-11-14: 406K2025-11-28: 394K2025-12-15: 387K2025-12-31: 325K2026-01-15: 358K2026-01-30: 371K2026-02-13: 355K2026-02-27: 348K2026-03-13: 450K2026-03-31: 391K2026-04-15: 351K2026-04-30: 447K2026-05-15: 409K2026-05-29: 503K2026-06-15: 465K2026-06-30: 519K2026-07-15: 747K2026-07-31: 672K2026-08-14: 787K2026-08-31: 1.2M2026-09-15: 1.3M
    the 15 Sep 2026 report24 earlier reportsnormal: 404K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 11 Sep 2026Short interest and volume change

    had 1.2M shares sold short in the 31 Aug 2026 report, 2.9× the same report last year.

    Same report last year: 419K; its normal report is 404K.

    See the evidence
    This period
    1.2M (the 31 Aug 2026 report)
    Normal report (median of 24 earlier)
    404K
    Typical spread (median absolute deviation)
    46K
    How far from its usual level
    +11.8
    Same report last year
    419K
    History used
    2,573 days
    2025-08-29: 419K2025-09-15: 461K2025-09-30: 403K2025-10-15: 384K2025-10-31: 394K2025-11-14: 406K2025-11-28: 394K2025-12-15: 387K2025-12-31: 325K2026-01-15: 358K2026-01-30: 371K2026-02-13: 355K2026-02-27: 348K2026-03-13: 450K2026-03-31: 391K2026-04-15: 351K2026-04-30: 447K2026-05-15: 409K2026-05-29: 503K2026-06-15: 465K2026-06-30: 519K2026-07-15: 747K2026-07-31: 672K2026-08-14: 787K2026-08-31: 1.2M
    the 31 Aug 2026 report24 earlier reportsnormal: 404K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 26 Aug 2026Short interest and volume change

    had 787K shares sold short in the 14 Aug 2026 report, 1.9× the same report last year.

    Same report last year: 423K; its normal report is 404K.

    See the evidence
    This period
    787K (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    404K
    Typical spread (median absolute deviation)
    44K
    How far from its usual level
    +5.9
    Same report last year
    423K
    History used
    2,556 days
    2025-08-15: 423K2025-08-29: 419K2025-09-15: 461K2025-09-30: 403K2025-10-15: 384K2025-10-31: 394K2025-11-14: 406K2025-11-28: 394K2025-12-15: 387K2025-12-31: 325K2026-01-15: 358K2026-01-30: 371K2026-02-13: 355K2026-02-27: 348K2026-03-13: 450K2026-03-31: 391K2026-04-15: 351K2026-04-30: 447K2026-05-15: 409K2026-05-29: 503K2026-06-15: 465K2026-06-30: 519K2026-07-15: 747K2026-07-31: 672K2026-08-14: 787K
    the 14 Aug 2026 report24 earlier reportsnormal: 404K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 12 Aug 2026Short interest and volume change

    had 672K shares sold short in the 31 Jul 2026 report, 1.4× the same report last year.

    Same report last year: 476K; its normal report is 404K.

    See the evidence
    This period
    672K (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    404K
    Typical spread (median absolute deviation)
    44K
    How far from its usual level
    +4.1
    Same report last year
    476K
    History used
    2,542 days
    2025-07-31: 476K2025-08-15: 423K2025-08-29: 419K2025-09-15: 461K2025-09-30: 403K2025-10-15: 384K2025-10-31: 394K2025-11-14: 406K2025-11-28: 394K2025-12-15: 387K2025-12-31: 325K2026-01-15: 358K2026-01-30: 371K2026-02-13: 355K2026-02-27: 348K2026-03-13: 450K2026-03-31: 391K2026-04-15: 351K2026-04-30: 447K2026-05-15: 409K2026-05-29: 503K2026-06-15: 465K2026-06-30: 519K2026-07-15: 747K2026-07-31: 672K
    the 31 Jul 2026 report24 earlier reportsnormal: 404K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 4 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 4 Jun 2026Filings record

    Director or officer change

  10. 5 Jun 2025Filings record

    Director or officer change

  11. 8 May 2025Financials change

    spent $15.5M on capital projects in the quarter ended 31 Mar 2025, 2.6× the same quarter last year.

    Same quarter last year: $6.0M; its normal quarter is $7.7M.

    See the evidence
    This period
    $15.5M (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    $7.7M
    Typical spread (median absolute deviation)
    $1.6M
    How far from its usual level
    +3.2
    Same quarter last year
    $6.0M
    History used
    2,374 days
    2023-03-31: $4.7M2023-06-30: $6.1M2023-09-30: $7.4M2023-12-31: $7.9M2024-03-31: $6.0M2024-06-30: $8.9M2024-09-30: $11.0M2024-12-31: $11.8M2025-03-31: $15.5M
    the quarter ended 31 Mar 20258 earlier quartersnormal: $7.7M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  12. 14 Apr 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 14 Apr 2025Filings record

    Director or officer change

  14. 6 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 6 Jun 2024Filings record

    Director or officer change

  16. 15 May 2024Insiders record

    Heltz Sabrina (director) bought 2,820 shares of VMD ($19,977) (dated 14 May 2024)

  17. 7 Nov 2023Financials change

    reported revenue of $49.4M for the quarter ended 30 Sep 2023, 1.4× the same quarter last year.

    Same quarter last year: $35.8M; its normal quarter is $34.5M.

    See the evidence
    This period
    $49.4M (the quarter ended 30 Sep 2023)
    Normal quarter (median of 8 earlier)
    $34.5M
    Typical spread (median absolute deviation)
    $2.8M
    How far from its usual level
    +3.6
    Same quarter last year
    $35.8M
    History used
    2,009 days
    2021-09-30: $29.3M2021-12-31: $32.0M2022-03-31: $32.3M2022-06-30: $33.3M2022-09-30: $35.8M2022-12-31: $37.5M2023-03-31: $39.6M2023-06-30: $43.3M2023-09-30: $49.4M
    the quarter ended 30 Sep 20238 earlier quartersnormal: $34.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  18. 13 Sep 2023Short interest and volume change

    had 512K shares sold short in the 31 Aug 2023 report, 3.7× the same report last year.

    Same report last year: 140K; its normal report is 137K.

    See the evidence
    This period
    512K (the 31 Aug 2023 report)
    Normal report (median of 24 earlier)
    137K
    Typical spread (median absolute deviation)
    26K
    How far from its usual level
    +7.5
    Same report last year
    140K
    History used
    1,477 days
    2022-08-31: 140K2022-09-15: 85K2022-09-30: 154K2022-10-14: 137K2022-10-31: 144K2022-11-15: 138K2022-11-30: 132K2022-12-15: 102K2022-12-30: 112K2023-01-13: 110K2023-01-31: 136K2023-02-15: 151K2023-02-28: 119K2023-03-15: 117K2023-03-31: 101K2023-04-14: 119K2023-04-28: 110K2023-05-15: 103K2023-05-31: 174K2023-06-15: 205K2023-06-30: 589K2023-07-14: 629K2023-07-31: 581K2023-08-15: 539K2023-08-31: 512K
    the 31 Aug 2023 report24 earlier reportsnormal: 137K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 25 Aug 2023Short interest and volume change

    had 539K shares sold short in the 15 Aug 2023 report, 3.1× the same report last year.

    Same report last year: 172K; its normal report is 137K.

    See the evidence
    This period
    539K (the 15 Aug 2023 report)
    Normal report (median of 24 earlier)
    137K
    Typical spread (median absolute deviation)
    26K
    How far from its usual level
    +8.0
    Same report last year
    172K
    History used
    1,461 days
    2022-08-15: 172K2022-08-31: 140K2022-09-15: 85K2022-09-30: 154K2022-10-14: 137K2022-10-31: 144K2022-11-15: 138K2022-11-30: 132K2022-12-15: 102K2022-12-30: 112K2023-01-13: 110K2023-01-31: 136K2023-02-15: 151K2023-02-28: 119K2023-03-15: 117K2023-03-31: 101K2023-04-14: 119K2023-04-28: 110K2023-05-15: 103K2023-05-31: 174K2023-06-15: 205K2023-06-30: 589K2023-07-14: 629K2023-07-31: 581K2023-08-15: 539K
    the 15 Aug 2023 report24 earlier reportsnormal: 137K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 10 Aug 2023Short interest and volume change

    had 581K shares sold short in the 31 Jul 2023 report, 3.4× the same report last year.

    Same report last year: 173K; its normal report is 137K.

    See the evidence
    This period
    581K (the 31 Jul 2023 report)
    Normal report (median of 24 earlier)
    137K
    Typical spread (median absolute deviation)
    26K
    How far from its usual level
    +8.9
    Same report last year
    173K
    History used
    1,446 days
    2022-07-29: 173K2022-08-15: 172K2022-08-31: 140K2022-09-15: 85K2022-09-30: 154K2022-10-14: 137K2022-10-31: 144K2022-11-15: 138K2022-11-30: 132K2022-12-15: 102K2022-12-30: 112K2023-01-13: 110K2023-01-31: 136K2023-02-15: 151K2023-02-28: 119K2023-03-15: 117K2023-03-31: 101K2023-04-14: 119K2023-04-28: 110K2023-05-15: 103K2023-05-31: 174K2023-06-15: 205K2023-06-30: 589K2023-07-14: 629K2023-07-31: 581K
    the 31 Jul 2023 report24 earlier reportsnormal: 137K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 26 Jul 2023Short interest and volume change

    had 629K shares sold short in the 14 Jul 2023 report, 2.5× the same report last year.

    Same report last year: 252K; its normal report is 137K.

    See the evidence
    This period
    629K (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    137K
    Typical spread (median absolute deviation)
    26K
    How far from its usual level
    +9.9
    Same report last year
    252K
    History used
    1,429 days
    2022-07-15: 252K2022-07-29: 173K2022-08-15: 172K2022-08-31: 140K2022-09-15: 85K2022-09-30: 154K2022-10-14: 137K2022-10-31: 144K2022-11-15: 138K2022-11-30: 132K2022-12-15: 102K2022-12-30: 112K2023-01-13: 110K2023-01-31: 136K2023-02-15: 151K2023-02-28: 119K2023-03-15: 117K2023-03-31: 101K2023-04-14: 119K2023-04-28: 110K2023-05-15: 103K2023-05-31: 174K2023-06-15: 205K2023-06-30: 589K2023-07-14: 629K
    the 14 Jul 2023 report24 earlier reportsnormal: 137K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 13 Jul 2023Short interest and volume change

    had 589K shares sold short in the 30 Jun 2023 report, 1.5× the same report last year.

    Same report last year: 390K; its normal report is 137K.

    See the evidence
    This period
    589K (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    137K
    Typical spread (median absolute deviation)
    26K
    How far from its usual level
    +9.0
    Same report last year
    390K
    History used
    1,415 days
    2022-06-30: 390K2022-07-15: 252K2022-07-29: 173K2022-08-15: 172K2022-08-31: 140K2022-09-15: 85K2022-09-30: 154K2022-10-14: 137K2022-10-31: 144K2022-11-15: 138K2022-11-30: 132K2022-12-15: 102K2022-12-30: 112K2023-01-13: 110K2023-01-31: 136K2023-02-15: 151K2023-02-28: 119K2023-03-15: 117K2023-03-31: 101K2023-04-14: 119K2023-04-28: 110K2023-05-15: 103K2023-05-31: 174K2023-06-15: 205K2023-06-30: 589K
    the 30 Jun 2023 report24 earlier reportsnormal: 137K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 1 Jun 2023Filings record

    Completed an acquisition or asset sale

  24. 29 Nov 2022Filings record

    A major agreement ended

  25. 17 Oct 2022Lobbying record

    VIEMED HEALTHCARE, INC.: lobbying engagement terminated (FORBES-TATE) (dated 1 Aug 2022)

  26. 20 Apr 2022Lobbying record

    THE PICARD GROUP OBO VIEMED: lobbying engagement terminated (CJ LAKE, LLC) (dated 1 Jan 2022)

  27. 9 Nov 2021Financials change

    spent $8.0M on capital projects in the quarter ended 30 Sep 2021, 3.2× the same quarter last year.

    Same quarter last year: $2.5M; its normal quarter is $2.8M.

    See the evidence
    This period
    $8.0M (the quarter ended 30 Sep 2021)
    Normal quarter (median of 8 earlier)
    $2.8M
    Typical spread (median absolute deviation)
    $726K
    How far from its usual level
    +4.8
    Same quarter last year
    $2.5M
    History used
    1,096 days
    2019-09-30: $2.9M2019-12-31: $2.8M2020-03-31: $4.2M2020-06-30: $1.5M2020-09-30: $2.5M2020-12-31: $4.8M2021-03-31: $1.8M2021-06-30: $3.2M2021-09-30: $8.0M
    the quarter ended 30 Sep 20218 earlier quartersnormal: $2.8M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  28. 26 Jun 2021Short interest and volume change

    had 1.8M shares sold short in the 15 Jun 2021 report, 3.4× the same report last year.

    Same report last year: 531K; its normal report is 1.3M.

    See the evidence
    This period
    1.8M (the 15 Jun 2021 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    92K
    How far from its usual level
    +3.5
    Same report last year
    531K
    History used
    670 days
    2020-06-15: 531K2020-06-30: 2.1M2020-07-15: 1.5M2020-07-31: 1.7M2020-08-14: 1.1M2020-08-31: 933K2020-09-15: 847K2020-09-30: 1.1M2020-10-15: 1.2M2020-10-30: 1.3M2020-11-13: 1.4M2020-11-30: 1.4M2020-12-15: 1.4M2020-12-31: 1.4M2021-01-15: 1.3M2021-01-29: 1.3M2021-02-12: 1.3M2021-02-26: 1.4M2021-03-15: 1.4M2021-03-31: 1.3M2021-04-15: 1.2M2021-04-30: 1.3M2021-05-14: 1.5M2021-05-28: 1.8M2021-06-15: 1.8M
    the 15 Jun 2021 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 15 Jan 2021Lobbying change

    reported $110K of lobbying spend for the quarter ended 31 Dec 2020, 4.4× its normal quarter.

    See the evidence
    This period
    $110K (the quarter ended 31 Dec 2020)
    Normal quarter (median of 6 earlier)
    $25K
    Typical spread (median absolute deviation)
    $5K
    How far from its usual level
    +4.2
    History used
    1,827 days
    2018-03-31: $30K2018-06-30: $20K2018-12-31: $20K2020-03-31: $20K2020-06-30: $40K2020-09-30: $90K2020-12-31: $110K
    the quarter ended 31 Dec 20206 earlier quartersnormal: $25K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  30. 9 Nov 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  31. 9 Nov 2020Filings record

    Director or officer change

  32. 13 Oct 2020Lobbying record

    THE PICARD GROUP OBO VIEMED: new lobbying registration (CJ LAKE, LLC) (dated 18 Mar 2020)

  33. 11 Sep 2020Short interest and volume change

    had 933K shares sold short in the 31 Aug 2020 report, 49× the same report last year.

    Same report last year: 19K; its normal report is 146K.

    See the evidence
    This period
    933K (the 31 Aug 2020 report)
    Normal report (median of 24 earlier)
    146K
    Typical spread (median absolute deviation)
    124K
    How far from its usual level
    +4.3
    Same report last year
    19K
    History used
    382 days
    2019-08-30: 19K2019-09-13: 26K2019-09-30: 34K2019-10-15: 33K2019-10-31: 25K2019-11-15: 17K2019-11-29: 93K2019-12-13: 93K2019-12-31: 93K2020-01-15: 84K2020-01-31: 153K2020-02-14: 127K2020-02-28: 138K2020-03-13: 217K2020-03-31: 546K2020-04-15: 400K2020-04-30: 448K2020-05-15: 311K2020-05-29: 385K2020-06-15: 531K2020-06-30: 2.1M2020-07-15: 1.5M2020-07-31: 1.7M2020-08-14: 1.1M2020-08-31: 933K
    the 31 Aug 2020 report24 earlier reportsnormal: 146K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 1 Sep 2020several at once

    reported revenue of $42.9M for the quarter ended 30 Jun 2020, 1.9× the same quarter last year, while it had 1.1M shares sold short in the 14 Aug 2020 report, 22× the same report last year. Two unrelated kinds of activity within 35 days.

    See the evidence (3 changes)

    Financials: Quarterly revenue change became public on 11 Aug 2020

    Viemed Healthcare reported revenue of $42.9M for the quarter ended 30 Jun 2020, 1.9× the same quarter last year.

    This period
    $42.9M (the quarter ended 30 Jun 2020)
    Normal quarter (median of 8 earlier)
    $19.9M
    Typical spread (median absolute deviation)
    $2.7M
    How far from its usual level
    +5.7
    Same quarter last year
    $22.5M
    History used
    822 days
    2018-06-30: $15.5M2018-09-30: $17.2M2018-12-31: $18.4M2019-03-31: $18.1M2019-06-30: $22.5M2019-09-30: $23.5M2019-12-31: $21.4M2020-03-31: $23.8M2020-06-30: $42.9M
    the quarter ended 30 Jun 20208 earlier quartersnormal: $19.9M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Short interest and volume: Short interest spike became public on 26 Aug 2020

    Viemed Healthcare had 1.1M shares sold short in the 14 Aug 2020 report, 22× the same report last year.

    This period
    1.1M (the 14 Aug 2020 report)
    Normal report (median of 24 earlier)
    133K
    Typical spread (median absolute deviation)
    107K
    How far from its usual level
    +6.1
    Same report last year
    50K
    History used
    365 days
    2019-08-15: 50K2019-08-30: 19K2019-09-13: 26K2019-09-30: 34K2019-10-15: 33K2019-10-31: 25K2019-11-15: 17K2019-11-29: 93K2019-12-13: 93K2019-12-31: 93K2020-01-15: 84K2020-01-31: 153K2020-02-14: 127K2020-02-28: 138K2020-03-13: 217K2020-03-31: 546K2020-04-15: 400K2020-04-30: 448K2020-05-15: 311K2020-05-29: 385K2020-06-15: 531K2020-06-30: 2.1M2020-07-15: 1.5M2020-07-31: 1.7M2020-08-14: 1.1M
    the 14 Aug 2020 report24 earlier reportsnormal: 133K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Sep 2020

    Viemed Healthcare had 933K shares sold short in the 31 Aug 2020 report, 49× the same report last year.

    This period
    933K (the 31 Aug 2020 report)
    Normal report (median of 24 earlier)
    146K
    Typical spread (median absolute deviation)
    124K
    How far from its usual level
    +4.3
    Same report last year
    19K
    History used
    382 days
    2019-08-30: 19K2019-09-13: 26K2019-09-30: 34K2019-10-15: 33K2019-10-31: 25K2019-11-15: 17K2019-11-29: 93K2019-12-13: 93K2019-12-31: 93K2020-01-15: 84K2020-01-31: 153K2020-02-14: 127K2020-02-28: 138K2020-03-13: 217K2020-03-31: 546K2020-04-15: 400K2020-04-30: 448K2020-05-15: 311K2020-05-29: 385K2020-06-15: 531K2020-06-30: 2.1M2020-07-15: 1.5M2020-07-31: 1.7M2020-08-14: 1.1M2020-08-31: 933K
    the 31 Aug 2020 report24 earlier reportsnormal: 146K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  35. 26 Aug 2020Short interest and volume change

    had 1.1M shares sold short in the 14 Aug 2020 report, 22× the same report last year.

    Same report last year: 50K; its normal report is 133K.

    See the evidence
    This period
    1.1M (the 14 Aug 2020 report)
    Normal report (median of 24 earlier)
    133K
    Typical spread (median absolute deviation)
    107K
    How far from its usual level
    +6.1
    Same report last year
    50K
    History used
    365 days
    2019-08-15: 50K2019-08-30: 19K2019-09-13: 26K2019-09-30: 34K2019-10-15: 33K2019-10-31: 25K2019-11-15: 17K2019-11-29: 93K2019-12-13: 93K2019-12-31: 93K2020-01-15: 84K2020-01-31: 153K2020-02-14: 127K2020-02-28: 138K2020-03-13: 217K2020-03-31: 546K2020-04-15: 400K2020-04-30: 448K2020-05-15: 311K2020-05-29: 385K2020-06-15: 531K2020-06-30: 2.1M2020-07-15: 1.5M2020-07-31: 1.7M2020-08-14: 1.1M
    the 14 Aug 2020 report24 earlier reportsnormal: 133K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  36. 26 Aug 2020Lobbying record

    VIEMED HEALTHCARE, INC.: new lobbying registration (FORBES-TATE) (dated 1 Aug 2020)

  37. 11 Aug 2020Financials change

    reported revenue of $42.9M for the quarter ended 30 Jun 2020, 1.9× the same quarter last year.

    Same quarter last year: $22.5M; its normal quarter is $19.9M.

    See the evidence
    This period
    $42.9M (the quarter ended 30 Jun 2020)
    Normal quarter (median of 8 earlier)
    $19.9M
    Typical spread (median absolute deviation)
    $2.7M
    How far from its usual level
    +5.7
    Same quarter last year
    $22.5M
    History used
    822 days
    2018-06-30: $15.5M2018-09-30: $17.2M2018-12-31: $18.4M2019-03-31: $18.1M2019-06-30: $22.5M2019-09-30: $23.5M2019-12-31: $21.4M2020-03-31: $23.8M2020-06-30: $42.9M
    the quarter ended 30 Jun 20208 earlier quartersnormal: $19.9M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  38. 11 Jun 2020Filings record

    Director or officer change

  39. 19 May 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  40. 19 May 2020Filings record

    Director or officer change

Showing the newest 40 of 46 entries; narrow the window or the kind of data to see older ones.

Not listed: 89 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001729149
Ticker
VMD
Domain
viemed.com
Hq location
LA|LAFAYETTE|70508 (1 unverified)
Lobbying client
picard group obo viemed, sleep management llc d b a viemed, viemed, viemed healthcare
Name
East Alabama HomeMed, LLC, Home Medical Products, Inc, Home Sleep Delivered, L.L.C, Lehan Drugs, Inc and 9 more
  • Federal lobbying disclosures (LDA)7 records, 73 data points19 Nov 2015 to 30 Sep 2026
  • SEC Form 13F institutional holdings293 data points31 Mar 2018 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)84 records31 Jan 2018 to 4 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)653 data points31 Dec 2017 to 27 Oct 2026
  • SEC Form 4 insider transactions17 records, 56 data points23 Dec 2022 to 26 Jun 2026
  • FINRA short interest (twice monthly)519 data points15 Aug 2019 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3658 data points9 Aug 2019 to 20 Nov 2026